<html><head>
<meta http-equiv="Content-Type" content="text/html; charset=utf-8">
</head><body>
<span style="position:absolute; border: gray 1px solid; left:0px; top:50px; width:612px; height:792px;"></span>
<div style="position:absolute; top:50px;"><a name="1">Page 1</a></div>
<div style="position:absolute; border: textbox 1px solid; writing-mode:lr-tb; left:92px; top:108px; width:465px; height:11px;"><span style="font-family: Arial,Bold; font-size:11px">The  Effect  of  Highly  Viscous  Fibre-Gel  on  Appetite  and  Glycemic  Response  in 
<br></span></div><div style="position:absolute; border: textbox 1px solid; writing-mode:lr-tb; left:56px; top:108px; width:504px; height:697px;"><span style="font-family: Arial,Bold; font-size:11px">5.   
<br>Healthy Individuals 
<br>(Fei Au-yueng) 
<br></span><span style="font-family: ABCDEE+Arial Bold,Bold; font-size:6px"> 
<br></span><span style="font-family: Arial,Italic; font-size:10px">Fei Au-Yeung*</span><span style="font-family: Arial,Italic; font-size:6px">1,2</span><span style="font-family: Arial,Italic; font-size:10px">, Elena Jovanovski</span><span style="font-family: Arial,Italic; font-size:6px">1,2</span><span style="font-family: Arial,Italic; font-size:10px">, Thanh Ho</span><span style="font-family: Arial,Italic; font-size:6px">1,2</span><span style="font-family: Arial,Italic; font-size:10px">, Andreea Zurbau</span><span style="font-family: Arial,Italic; font-size:6px">1,2</span><span style="font-family: Arial,Italic; font-size:10px">, Alexandra L Jenkins</span><span style="font-family: Arial,Italic; font-size:6px">2</span><span style="font-family: Arial,Italic; font-size:10px">, Vladimir 
<br>Vuksan</span><span style="font-family: Arial,Italic; font-size:6px">1,2,3,4,5</span><span style="font-family: Arial,Italic; font-size:10px"> 
<br></span><span style="font-family: Arial,Italic; font-size:6px">1</span><span style="font-family: Arial,Italic; font-size:10px">Department of Nutritional Sciences, Faculty of Medicine, University of Toronto, ON, Canada; </span><span style="font-family: Arial,Italic; font-size:6px">2</span><span style="font-family: Arial,Italic; font-size:10px">Clinical 
<br>Nutrition and Risk Factor Modification Centre, St. Michael’s Hospital, Toronto, ON, Canada; 
<br></span><span style="font-family: Arial,Italic; font-size:6px">3</span><span style="font-family: Arial,Italic; font-size:10px">Department of Medicine, Faculty of Medicine, University of Toronto, Toronto, ON, Canada; </span><span style="font-family: Arial,Italic; font-size:6px">4</span><span style="font-family: Arial,Italic; font-size:10px">Keenan 
<br>Research Centre of the Li Ka Shing Knowledge Institute, St. Michael’s Hospital, Toronto, ON, Canada; 
<br></span><span style="font-family: Arial,Italic; font-size:6px">5</span><span style="font-family: Arial,Italic; font-size:10px">Division of Endocrinology &amp; Metabolism, St. Michael's Hospital, Toronto, ON., Canada 
<br></span><span style="font-family: Arial; font-size:6px"> 
<br></span><span style="font-family: Arial,Bold; font-size:10px">Objective:</span><span style="font-family: Arial; font-size:10px"> Konjac-glucomannan (KGM) is a viscous dietary fibre that has been indicated in the 
<br>treatment of body weight and diabetes. Pre-hydration of KGM greatly changes its physicochemical 
<br>properties but little is known about its health benefits. Thus, we aim to assess the acute effects of 
<br>KGM administered in the form of a powder or a pre-hydrated gel on appetite and glycemic response. 
<br></span><span style="font-family: Arial,Bold; font-size:10px">Methods:</span><span style="font-family: Arial; font-size:10px"> Following a randomized, double-blinded, cross-over design, participants were administered 
<br>1 of 5 test meals on 5 separate occasions with &gt;2 day washout period. Each meal consisted of 50g 
<br></span><span style="font-family: Arial; font-size:10px">carbohydrates (CHO) in the form of bread, margarine, and a gel dessert. The test conditions were: 
<br>50g CHO in bread with 5g KGM as a powder (50PK) or pre-hydrated into the gel KGM (50GK) or a 
<br>fibre free control (50C), and 25g CHO in bread with 25g CHO in gel dessert with 5g KGM pre-hydrated 
<br>into the gel (25GK) or fibre free control (25C). All test meals were identical except for the form of fibre. 
<br>A standardized lunch was consumed 180min later. Satiety was recorded using visual analogue scales.  
<br></span><span style="font-family: Arial,Bold; font-size:10px">Results:</span><span style="font-family: Arial; font-size:10px"> Eighteen healthy individuals (M: 7/F: 11; Age: 28.6 ± 3yrs; BMI: 23.3 ± 0.7kg/m</span><span style="font-family: Arial; font-size:6px">2</span><span style="font-family: Arial; font-size:10px">) were 
<br>enrolled and 15 provided blood samples. The iAUC after 120 min for blood glucose was lower after 
<br>50PK (MD: -40%, p&lt;0.001) and 50GK (MD: -23%, p=0.049) vs. 50C. No differences were observed 
<br>between 50PK and 50GK (p=0.16). Additionally, 50GK increased satiety after 120 min vs. 50PK (MD: 
<br>+26%, p=0.035) and 50C (MD: +28%, p=0.025). The iAUC after 120 min for blood glucose was lower 
<br>in 25GK vs. 25C (MD: -28%, p=0.006), but no significant differences were observed in satiety. 
<br></span><span style="font-family: Arial,Bold; font-size:10px">Conclusions: </span><span style="font-family: Arial; font-size:10px">These findings suggest that KGM may improve glycemic control irrespective of 
<br>administration mode, but consumption in a pre-hydrated gel may confer additional benefits from 
<br>improved satiety and should be further explored. 
<br></span><span style="font-family: Arial,Bold; font-size:10px">Protocol registration</span><span style="font-family: Arial; font-size:10px">: Clinicaltrials.gov identifier, NCT01657058 
<br></span><span style="font-family: Arial,Bold; font-size:10px">Funding:</span><span style="font-family: Arial; font-size:10px"> This project was internally funded by St. Michael’s Hospital. 
<br></span><span style="font-family: Times New Roman; font-size:10px"> 
<br></span><span style="font-family: Arial,Bold; font-size:10px"> 
<br></span><span style="font-family: Arial,Bold; font-size:11px">6.    A Randomized Crossover Trial Of Walking After Eating And Standard Physical 
<br>Activity Advice In T2DM: Participant Acceptability And Compliance  
<br></span><span style="font-family: Arial,Bold; font-size:11px">(Bernard Venn) 
<br></span><span style="font-family: Arial; font-size:6px"> 
<br></span><span style="font-family: Arial,Italic; font-size:10px">Andrew N Reynolds</span><span style="font-family: Arial,Italic; font-size:6px">1,2</span><span style="font-family: Arial,Italic; font-size:10px">, Bernard J Venn</span><span style="font-family: Arial,Italic; font-size:6px">1</span><span style="font-family: Arial,Italic; font-size:10px">*, Sheila Williams</span><span style="font-family: Arial,Italic; font-size:6px">3</span><span style="font-family: Arial,Italic; font-size:10px">, Jim I Mann</span><span style="font-family: Arial,Italic; font-size:6px">1, 2, 4 
<br>1 </span><span style="font-family: Arial,Italic; font-size:10px">Department of Human Nutrition, University of Otago, Dunedin New Zealand; </span><span style="font-family: Arial,Italic; font-size:6px">2 </span><span style="font-family: Arial,Italic; font-size:10px">Edgar National Centre 
<br>for Diabetes and Obesity Research, Dunedin New Zealand; </span><span style="font-family: Arial,Italic; font-size:6px">3 </span><span style="font-family: Arial,Italic; font-size:10px">Department of Preventive and Social 
<br>Medicine, University of Otago, Dunedin New Zealand; </span><span style="font-family: Arial,Italic; font-size:6px">4 </span><span style="font-family: Arial,Italic; font-size:10px">Faculty of Medicine, University of Otago, 
<br>Dunedin New Zealand 
<br></span><span style="font-family: Arial; font-size:10px">Email: bernard.venn@otago.ac.nz 
<br></span><span style="font-family: Arial; font-size:7px"> 
<br></span><span style="font-family: Arial,Bold; font-size:10px">Objective: </span><span style="font-family: Arial; font-size:10px">To compare participant acceptability and compliance to two approaches of increasing 
<br></span><span style="font-family: Arial; font-size:10px">physical activity in people with T2DM. 
<br></span><span style="font-family: Arial,Bold; font-size:10px">Methods:</span><span style="font-family: Arial; font-size:10px"> Forty-one T2DM adults (HbA1</span><span style="font-family: Arial; font-size:6px">c</span><span style="font-family: Arial; font-size:10px"> 58.9 mmol/mol) completed two 2-week interventions in 
<br>randomized order of a 30-minute walk per day and walking for 10-minutes after each main meal with a 
<br>four-week washout. Compliance with walking regimens was captured by tri-axial accelerometers 
<br>(GT3X, ActiGraph). Walking preference and measures of motivation for physical activity were 
<br>recorded pre- and post-intervention measured on a five-point Likert scale. 
<br></span><span style="font-family: ABCDEE+Calibri; font-size:11px">67 
<br> 
<br></span></div><span style="position:absolute; border: black 1px solid; left:55px; top:690px; width:501px; height:12px;"></span>
<span style="position:absolute; border: black 1px solid; left:55px; top:703px; width:501px; height:12px;"></span>
<span style="position:absolute; border: black 1px solid; left:55px; top:716px; width:501px; height:12px;"></span>
<span style="position:absolute; border: black 1px solid; left:55px; top:728px; width:501px; height:12px;"></span>
<span style="position:absolute; border: black 1px solid; left:55px; top:741px; width:501px; height:12px;"></span>
<span style="position:absolute; border: black 1px solid; left:55px; top:754px; width:501px; height:12px;"></span>
<span style="position:absolute; border: black 1px solid; left:55px; top:766px; width:501px; height:12px;"></span>
<div style="position:absolute; top:0px;">Page: <a href="#1">1</a></div>
</body></html>
